Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 8Uterine Cervical Neoplasms 6Carcinoma, Renal Cell 5Rectal Neoplasms 4Pancreatic Neoplasms 4Colonic Neoplasms 4Sarcoma 3Neoplasms 3Lymphoma 3Lung Neoplasms 3Hodgkin Disease 3Breast Neoplasms, Male 3Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Adenocarcinoma, Follicular 2von Hippel-Lindau Disease 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Stage III Lung Non-Small Cell Cancer AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1

Interventions

Cisplatin 13Radiotherapy, Intensity-Modulated 11Radiotherapy 5Carboplatin 5Radiation 4Cetuximab 4durvalumab 3Platinum 3Nivolumab 31,2-diaminocyclohexaneplatinum II citrate 3pembrolizumab 2fludarabine phosphate 2fludarabine 2aldesleukin 2Specimen Handling 2Restraint, Physical 2Paclitaxel 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Bupropion 2Biopsy 2Acupuncture Therapy 2veliparib 1utomilumab 1sodium thiosulfate 1ficlatuzumab 1dehydroftorafur 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Oropharyngeal Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT01806675 2019-10-03

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Stanford University

Phase 1/2 Completed
25 enrolled 14 charts
BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Gliosarcoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡